Vivienne SpanopoulosmHBOT vs ‘Just Breathing Oxygen’: What’s the Actual Difference?
Mild Hyperbaric Oxygen Therapy (mHBOT) is often misunderstood as simply “breathing oxygen in a different way.” In reality, the distinction is far more significant—and it lies in the application of pressure, which fundamentally changes how oxygen behaves in the body.
When we breathe oxygen at normal atmospheric pressure, even in enriched oxygen environments, it is primarily carried by haemoglobin in red blood cells. This is effective, but it has a physiological ceiling. The body can only transport so much oxygen this way.
mHBOT introduces a different mechanism. Inside a pressurised chamber—typically 1.3 to 2.0 times normal atmospheric pressure (ATA) —oxygen dissolves directly into the plasma, cerebrospinal fluid, and other bodily fluids. This allows oxygen to reach areas with restricted blood flow, inflammation, or injury in a way that conventional breathing cannot achieve.
This enhanced oxygen delivery is where mHBOT becomes particularly interesting in both clinical and integrative health settings.
Over the past several decades, a growing body of research and clinical observation has explored mHBOT’s role as a supportive therapy in a range of conditions. In wound healing, for example, mHBOT has been widely studied for its ability to accelerate tissue repair, particularly in chronic or non-healing wounds, where oxygen deprivation is a limiting factor.
In neurological applications, emerging research has explored mHBOT’s potential in supporting recovery following traumatic brain injury, stroke, and neuroinflammatory conditions. Some studies have reported improvements in cognitive function, brain metabolism, and quality-of-life measures, particularly in individuals with persistent post-injury symptoms. While not considered a standalone treatment, mHBOT is increasingly being investigated as a rehabilitative adjunct that may help support neurological repair processes.
There is also growing interest in its effects on the immune system and systemic inflammation. Improved oxygen availability is thought to support cellular repair mechanisms, modulate inflammatory responses, and enhance mitochondrial function—factors that may contribute to increased resilience and vitality.
Many people who undergo a structured course of mHBOT also report subjective improvements such as increased energy, clearer cognition, improved recovery from physical exertion, and better overall well-being. While individual responses vary, these observations are consistent enough to have driven continued clinical interest worldwide.
mHBOT is not typically a one-off treatment but rather a cumulative process. Most protocols begin with 10–20 sessions, allowing the body to adapt and respond. For more complex or chronic concerns, programs may extend to 30–40 sessions or more, often delivered 3–5 times per week in an initial phase, followed by maintenance sessions depending on individual goals and practitioner guidance.
Ultimately, the key distinction is not oxygen itself, but what happens when oxygen is delivered under pressure. mHBOT creates a physiological environment in which oxygen can reach deeper, more compromised tissues, opening new possibilities for recovery, repair, and regenerative support.
Scalar Lounge currently has Launch specials available for your mHBOT packages. Enquire with us for details or click here for pricing tables: https://scalarlounge.org/pricing/
Vivienne Spanopoulos is the founder of Scalar Lounge Brisbane. Scalar Lounge is a holistic wellness space dedicated to restoring coherence and consciousness through advanced technologies such as mHBOT and The Light System (TLS). Learn more at www.scalarlounge.org.
Book a session for mHBOT: https://scalarlounge.org/mhbot/
Follow us: Instagram: @scalarlounge · Facebook: Scalar Lounge
Contact: info@scalarlounge.org · 0483 219 512
Gerard Bini
Charlie Lally
Add comment